These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)]. Fröscher W; Schulz HU; Gugler R Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872 [TBL] [Abstract][Full Text] [Related]
5. Valproic acid (Depakene). A new anticonvulsant agent. Lewis JR JAMA; 1978 Nov; 240(20):2190-2. PubMed ID: 100622 [TBL] [Abstract][Full Text] [Related]
6. [Possible uses of Convulsofin liquid in the treatment of pediatric epilepsies]. Klepel H; Koch RD; Tzenow H Psychiatr Neurol Med Psychol (Leipz); 1986 Mar; 38(3):142-7. PubMed ID: 3086910 [TBL] [Abstract][Full Text] [Related]
7. Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy. Pinder RM; Brogden RN; Speight TM; Avery GS Drugs; 1977 Feb; 13(2):81-123. PubMed ID: 402258 [TBL] [Abstract][Full Text] [Related]
8. Sodium valproate in the treatment of resistant epilepsy. Hassan MN; Laljee HC; Parsonage MJ Acta Neurol Scand; 1976 Sep; 54(3):209-218. PubMed ID: 822682 [TBL] [Abstract][Full Text] [Related]
9. Role of valproate across the ages. Treatment of epilepsy in children. Aldenkamp A; Vigevano F; Arzimanoglou A; Covanis A Acta Neurol Scand Suppl; 2006; 184():1-13. PubMed ID: 16776492 [TBL] [Abstract][Full Text] [Related]
10. Sodium di-N-propylacetate (DPA) in the treatment of epilepsy. A review. Simon D; Penry JK Epilepsia; 1975 Nov; 16(4):549-73. PubMed ID: 812693 [TBL] [Abstract][Full Text] [Related]
12. Treatment of generalized epilepsies of childhood and adolescence with sodium valproate ("epilim"). Jeavons PM; Clark JE; Maheshwari MC Dev Med Child Neurol; 1977 Feb; 19(1):9-25. PubMed ID: 403104 [TBL] [Abstract][Full Text] [Related]
13. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Davis R; Peters DH; McTavish D Drugs; 1994 Feb; 47(2):332-72. PubMed ID: 7512905 [TBL] [Abstract][Full Text] [Related]
14. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080 [TBL] [Abstract][Full Text] [Related]
15. Use of ethosuximide and valproate in the treatment of epilepsy. Wallace SJ Neurol Clin; 1986 Aug; 4(3):601-16. PubMed ID: 3092003 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. Perucca E CNS Drugs; 2002; 16(10):695-714. PubMed ID: 12269862 [TBL] [Abstract][Full Text] [Related]
17. [Effect of valproate monotherapy on spike-wave activity in generalized epilepsies (author's transl)]. Stefan H; Hoffmann F; Burr W; Fröscher W; Penin H Nervenarzt; 1981 Dec; 52(12):707-14. PubMed ID: 6798478 [No Abstract] [Full Text] [Related]
18. Sodium valproate monotherapy in childhood epilepsy. Dulac O; Steru D; Rey E; Perret A; Arthuis M Brain Dev; 1986; 8(1):47-52. PubMed ID: 3085530 [TBL] [Abstract][Full Text] [Related]
19. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. de Silva M; MacArdle B; McGowan M; Hughes E; Stewart J; Neville BG; Johnson AL; Reynolds EH Lancet; 1996 Mar; 347(9003):709-13. PubMed ID: 8601999 [TBL] [Abstract][Full Text] [Related]
20. Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock. Borowicz KK; Malek R; Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ Epilepsy Behav; 2007 Aug; 11(1):6-12. PubMed ID: 17602881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]